Stay updated on Aducanumab in Early Alzheimer's Clinical Trial

Sign up to get notified when there's something new on the Aducanumab in Early Alzheimer's Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Aducanumab in Early Alzheimer's Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2 and removed the government funding lapse notice as well as Revision: v3.4.1.
    Difference
    0.2%
    Check dated 2026-02-11T14:09:00.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    Administrative updates were made to the study page: a government funding status notice was added, a new 2023 publication entry was added, a record revision labeled v3.4.1 was noted, and an earlier Erratum publication entry was removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-02-04T10:27:26.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    Added Show glossary and updated revision metadata to Revision: v3.4.0; adjusted QC and FEAR Act labels (e.g., capitalization) replacing previous variants.
    Difference
    0.1%
    Check dated 2026-01-28T06:18:27.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.3.4, replacing Revision: v3.3.3.
    Difference
    0.0%
    Check dated 2026-01-14T03:40:48.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    Publication details for 'Characterization of exposure-Clinical Dementia Rating-Sum of Boxes relationship in subjects with early Alzheimer's disease from the aducanumab Phase 3 trials' were updated to include the Erratum and corrected bibliographic details. This is a bibliographic update in the Publications section and does not affect study design or results.
    Difference
    0.0%
    Check dated 2026-01-07T01:54:30.000Z thumbnail image
  7. Check
    63 days ago
    Change Detected
    Summary
    Expanded the Locations section to include a comprehensive list of trial sites across multiple US states and international regions (e.g., Australia, Canada, Europe, and Asia). Several previous location groupings were removed.
    Difference
    3%
    Check dated 2025-12-23T20:43:14.000Z thumbnail image

Stay in the know with updates to Aducanumab in Early Alzheimer's Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Aducanumab in Early Alzheimer's Clinical Trial page.